Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia

Neurourology and Urodynamics

Volumn 25, Issue 2, 2006, Pages 105-109

  Rembratt, A ^a,b   Riis, A ^b   Norgaard, J P ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Ferring Pharmaceuticals AS   (Denmark)

Author keywords

Elderly; Safety; Serum sodium

Indexed keywords

DESMOPRESSIN;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; ELDERLY CARE; FATIGUE; FEMALE; HUMAN; HYPONATREMIA; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NOCTURIA; PATIENT MONITORING; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SODIUM BLOOD LEVEL; TREATMENT CONTRAINDICATION; URINE VOLUME; VOMITING; WEIGHT GAIN;

ADULT; AGED; DATABASES, FACTUAL; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; HYPONATREMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RENAL AGENTS; RISK FACTORS; SODIUM; URINATION DISORDERS;

EID: 33644910200     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20168     Document Type: Article

References (13)

1. Chan T. 1997. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Drugs & Aging 11:27-44.
2. Drincic AT, Robertson GL. 1999. Treatment of diabetes insipidus in adults. In: Meikle AW, editor. Contemporary endocrinology: Hormone replacement therapy. Totowa: Humana Press, Inc. pp 21-38.
3. Glazener CMA, Evans JHC. 2002. Desmopressin for nocturnal enuresis in children. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No.: CD002112. DOI: 10.1002/14651858.CD002112.
4. Jackson S. 1999. Lower urinary tract symptoms and nocturia in men and women: Prevalence, aetiology and diagnosis. BJU Int 84(Suppl 1):5-8.
5. Ledingham J, Crowe M, Forsling M, et al. 1987. Effects of aging on vasopressin secretion, water excretion and thirst in man. Kidney Int 32:S90-2.
6. Lose G, Lalos O, Freeman R, et al. 2003. Efficacy of desmopressin (Minirin) in the treatment of nocturia: A double-blind placebo-controlled study in women. Am J Obstet Gynecol 189:1106-13.
7. Lose G, Mattiasson A, Walter S, et al. 2004. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol 172:1021-5.
8. Mattiasson A, Abrams P, van Kerrebroeck P, et al. 2002. Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men. BJU Int 89:855-62.
9. Miller M. 1997. Fluid and electrolyte homeostasis in the elderly: Physiological changes of ageing and clinical consequences. Baillière's Clin Endocrinol Metab 11:367-87.
10. Rembratt A, Norgaard P, Andersson K-E. 2003. Desmopressin in elderly patients with nocturia: Short-term safety and effects on urine output, sleep and voiding patterns. BJU Int 91:642-6.
11. van Kerrebreck P, Abrams P, Chaikin D, et al. 2002. The standardisation of terminology in nocturia:Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:179-83.
12. van Kerrebroeck P, Rezapour M, Thüroff J, et al. 2002. Efficacy and safety of oral desmopressin (MINIRIN) in treatment of nocturia in men and women. Int Urogynecol J 13:S5-6.
13. Weatherall M. 2004. The risk of hyponatremia in older adults using desmopressin for nocturia: A systematic review and meta-analysis. Neurourol Urodyn 23:302-5.